Today: 7 February 2026
Subscribe
Browse Category

Medical Technology News 25 December 2025 - 11 January 2026

Intuitive Surgical stock: Bernstein lifts ISRG target as JPM conference week begins

Intuitive Surgical stock: Bernstein lifts ISRG target as JPM conference week begins

New York, Jan 11, 2026, 16:22 EST — Market closed. Bernstein bumped up its price target on Intuitive Surgical (ISRG.O) to $740 from $700, maintaining an “Outperform” rating. The robotic surgery firm’s shares closed Friday up 0.2% at $586.24, after trading between $579.62 and $589.58. Its 52-week range stands at $425 to $616. (GuruFocus) U.S. markets are closed Sunday, yet the schedule keeps moving. J.P. Morgan’s annual Healthcare Conference takes place Jan. 12–15 in San Francisco. Intuitive is set to present at 9:00 a.m. PT on Wednesday. After that event, the next earnings report is expected around Jan. 22, according
11 January 2026
·······
Why Intuitive Surgical stock (ISRG) is back in focus after Bernstein lifts its target

Why Intuitive Surgical stock (ISRG) is back in focus after Bernstein lifts its target

New York, Jan 10, 2026, 16:37 EST — The market is closed. On Friday, Bernstein lifted its price target for Intuitive Surgical from $700 to $740, maintaining an Outperform rating. The move signals strong confidence as healthcare investors brace for a hectic period. (TipRanks) Intuitive Surgical shares ended Friday up 0.2%, closing at $586.24. During the day, the stock fluctuated between $579.62 and $589.58. Its 52-week range stands at $425 to $616, per Stock Analysis. (StockAnalysis) Why it matters now: investors are focused on the J.P. Morgan Healthcare Conference, set for Jan. 12-15 in San Francisco, while also waiting on
10 January 2026
·····
Abbott Laboratories stock drifts into earnings after Canada widens Libre 3 Plus coverage

Abbott Laboratories stock drifts into earnings after Canada widens Libre 3 Plus coverage

New York, January 10, 2026, 16:02 EST — Market closed Abbott Laboratories (ABT) said its FreeStyle Libre 3 Plus glucose sensor is now publicly funded across every province in Canada. The stock ended down 0.2% at $125.92 on Friday. (Nasdaq) The update lands with investors turning back to Abbott’s diabetes-device franchise heading into fourth-quarter results later this month. Abbott said it will report before the U.S. market opens on Jan. 22 and host a webcast that morning. (Abbott MediaRoom) Analysts have started to revisit targets on large-cap healthcare names after a shaky 2025 run. Bernstein analyst Lee Hambright raised Abbott’s
10 January 2026
·····
Intuitive Surgical stock steadies after-hours as Barclays lifts target; da Vinci 5 bets build

Intuitive Surgical stock steadies after-hours as Barclays lifts target; da Vinci 5 bets build

New York, Jan 7, 2026, 20:13 ET — After-hours Intuitive Surgical (ISRG.O) shares eased about 0.1% in after-hours trading on Wednesday to $592.27, after Barclays raised its price target on the robotic-surgery leader to $686 from $635 and kept an “Overweight” rating. The stock traded between $590 and $603.75 during the regular session. TipRanks The calls land as ISRG flirts with its recent highs and investors keep trying to pin down the next leg of growth: how quickly hospitals upgrade to the company’s newest da Vinci systems, and what that means for recurring sales. For Intuitive, the hardware sale is
8 January 2026
·····
Johnson & Johnson stock rises on Ottava robot FDA filing as investors scan pipeline updates

Johnson & Johnson stock rises on Ottava robot FDA filing as investors scan pipeline updates

New York, Jan 7, 2026, 14:25 EST — Regular session Johnson & Johnson shares rose 0.9% to $206.62 on Wednesday, after the healthcare company said it filed its OTTAVA robotic surgical system with U.S. regulators. The stock traded between $204.62 and $208.25. The filing puts fresh attention on J&J’s MedTech push, a part of the business investors want to see grow as hospitals spend on new tools and procedures. A credible path to market for a surgical robot would also set up a direct fight in a field dominated by Intuitive Surgical. It lands at a busy moment for the
7 January 2026
·····
4DMedical shares jump on UC San Diego Health CT:VQ rollout as market eyes next catalyst

4DMedical shares jump on UC San Diego Health CT:VQ rollout as market eyes next catalyst

Sydney, Jan 7, 2026, 17:44 AEDT — Market closed Shares of 4DMedical Ltd (ASX:4DX) climbed 11.9% to close at A$4.69 on Wednesday after the firm said UC San Diego Health had adopted its CT:VQ lung imaging software for clinical use. About 12.8 million shares traded, MarketScreener data showed. MarketScreener+1 The contract adds a fourth U.S. academic medical centre — a university-linked teaching hospital — to deploy CT:VQ since the product won U.S. Food and Drug Administration clearance in August, sharpening investor focus on commercial traction. UCSD will use introductory pricing through March 31 before moving to full commercial terms, the
7 January 2026
····
Intuitive Surgical stock jumps on heavy volume as ISRG nears 52-week high ahead of key January dates

Intuitive Surgical stock jumps on heavy volume as ISRG nears 52-week high ahead of key January dates

New York, January 6, 2026, 21:40 EST — Market closed Intuitive Surgical (ISRG) shares rose 4.7% on Tuesday to close at $592.85, outpacing several large-cap medical device peers as U.S. stocks advanced broadly. MarketWatch The gain left the surgical-robot maker about 3.8% below its 52-week high of $616, a level some investors view as a near-term marker after the stock’s sharp run since early January. MarketWatch That matters now because Intuitive is entering a stretch when management commentary can reset expectations, with investors looking for early signals on demand and margins before the next earnings update. Intuitive+1 Tuesday’s session was
7 January 2026
·····
Intuitive Surgical stock falls today: what’s driving ISRG and what investors watch next

Intuitive Surgical stock falls today: what’s driving ISRG and what investors watch next

NEW YORK, January 2, 2026, 3:30 PM ET — Regular session Intuitive Surgical shares slid 1% to $560.61 in afternoon trading on Friday, lagging a mixed U.S. tape in the market’s first session of 2026. The drop matters because investors are starting the year with fresh sensitivity to valuation—how much they are paying for a dollar of earnings—after a strong 2025 run left many stocks priced for good news. Reuters “Stocks trade expensive on 18 of 20 measures, and we see elevated risks to the index level in the near term,” Savita Subramanian, Bank of America’s equity and quant strategist,
2 January 2026
·····
Bupa renews ParalympicsGB partnership and seals Nuffield Health deal as robotic knee surgery hits 1,000 mark

Bupa renews ParalympicsGB partnership and seals Nuffield Health deal as robotic knee surgery hits 1,000 mark

NEW YORK, January 1, 2026, 06:51 ET Bupa UK on Wednesday renewed its role as Official Healthcare Partner of ParalympicsGB and agreed a new three-year contract between Bupa UK Insurance and Nuffield Health, the company said. The Nuffield agreement adds direct appointment booking and wider access to diagnostics for Bupa customers. (Source) The moves matter because speed to diagnosis is a selling point in private healthcare, where delays between referral, scans and treatment can drive customer frustration. Bupa is also tying its brand to elite sport at a time when sponsors are under pressure to show measurable health outcomes. For
1 January 2026
··
Heartflow stock drops nearly 3% today as year-end trading thins; what investors watch next

Heartflow stock drops nearly 3% today as year-end trading thins; what investors watch next

NEW YORK, December 31, 2025, 13:57 ET — Regular session Heartflow Inc shares fell 2.8% to $29.35 by early afternoon on Wednesday, after trading between $29.26 and $30.97. Volume was about 336,000 shares. The drop outpaced a small decline in the broader market, with the S&P 500 tracker SPY down about 0.2% and the Nasdaq 100 tracker QQQ off roughly 0.2%. The health-care sector ETF XLV dipped about 0.1%, while the U.S. medical devices ETF IHI fell about 0.3%. The move comes in a typically thin year-end session, with U.S. stock markets open for regular hours on New Year’s Eve
31 December 2025
····
Intuitive Surgical (ISRG) Stock: What to Know Before the Market Opens on Dec. 26, 2025

Intuitive Surgical (ISRG) Stock: What to Know Before the Market Opens on Dec. 26, 2025

Intuitive Surgical, Inc. (NASDAQ: ISRG) heads into the Friday, December 26, 2025 U.S. trading session with investor attention split between strong operating momentum in robotic-assisted surgery and a fresh mix of regulatory and corporate updates that could shape near-term sentiment. After the last regular U.S. session ahead of today’s open, ISRG shares were around $577.15. Below is what investors and traders typically want on their radar before the bell—from the most recent FDA-related headlines and recall database entries to analyst forecasts, technical levels, and the next major catalyst on the calendar. Where ISRG stock stands heading into Dec. 26 ISRG
26 December 2025
·····
Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

December 25, 2025 — Intuitive Surgical, Inc. (NASDAQ: ISRG) is ending 2025 with two storylines that rarely move in sync: fresh regulatory momentum for its single-port robotic platform and a renewed valuation debate as analysts model what the next wave of procedure growth could look like in 2026. With U.S. markets closed for Christmas Day, ISRG was last quoted around the $578 level at the December 24 close, setting the stage for the next major catalyst: Intuitive’s Q4 2025 earnings expected in late January. MarketBeat Below is a comprehensive wrap of the latest news, forecasts, and analyst analysis available as
25 December 2025
····
1 2 3 4 5 6

Stock Market Today

Eli Lilly stock rises after FDA steps up crackdown on GLP-1 copycats

Eli Lilly stock rises after FDA steps up crackdown on GLP-1 copycats

7 February 2026
Eli Lilly shares climbed 3.7% in after-hours trading after the FDA announced plans to restrict GLP-1 ingredients in unapproved compounded drugs. Hims & Hers shares dropped nearly 12% after being referred for a Justice Department probe. Investors are watching for details on enforcement and pricing pressure as the market reacts to moves against copycat obesity drugs.
IREN stock whipsaws after earnings as bitcoin rebounds; Microsoft GPU financing in focus

IREN stock whipsaws after earnings as bitcoin rebounds; Microsoft GPU financing in focus

7 February 2026
IREN Limited shares rose 5.1% to $41.83 in after-hours trading Friday as bitcoin jumped 11.4% to $71,198, lifting crypto-linked stocks. The company reported $184.7 million in quarterly revenue, with $167.4 million from bitcoin mining and $17.3 million from AI cloud services. Net loss reached $155.4 million. IREN recently announced $3.6 billion in GPU financing for a Microsoft contract and a new Oklahoma data center.
Netflix stock price rises after-hours as DOJ widens scrutiny of Warner deal

Netflix stock price rises after-hours as DOJ widens scrutiny of Warner deal

7 February 2026
The U.S. Justice Department is investigating Netflix’s business practices as part of its review of the proposed Warner Bros Discovery deal, the Wall Street Journal reported Friday. Netflix shares rose 1.6% to $82.20 in after-hours trading. Warner expects a shareholder vote on the deal in March. Paramount Skydance’s rival bid remains active.
Go toTop